We therefore conducted the POC-HF pilot study with the goal to assess whether serial NT-proBNP measurements influence treatment decisions, such as dose adjustment of prognostically beneficial HF medication, and outcomes in patients hospitalized for ADHF. This evidence concerns the gene NPPB and hydrops fetalis.